WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List Reform ... The NHSA has released for public consultation a set of draft policy documents outlining the 2025 adjustment framework for the NRDL and a separate list for commercial heal...
(7/1/2025)

FDA's Crackdown and China's Dealmaking: Warnin... (7/2/2025)

Medical Advances Soar With APAC's Clinical Tri... (7/2/2025)

Tracking the Crossroads of Policy, Innovation,... (7/1/2025)

BeOne Launches Phase III Trial Comparing Subcu... (7/1/2025)

China Launches Landmark Measures to Boost Inno... (7/1/2025)

Analyzing Key Trends in China's Patent-Linkage... (6/27/2025)

Fresh Antitrust Guidelines to Address Pharmace... (6/27/2025)

Breaking the Boundaries: A New Map of Physicia... (6/25/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

CDE Annual Report Reveals Strong Growth and Ev... (6/19/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

CDE Solicits Comments on the 95th Batch ... (7/4/2025) CDE Seeks Comment on Revised eCTD Techni... (7/4/2025) AstraZeneca Eyes $15B Deal for Summit's ... (7/4/2025) Legend Initiates First-in-Human Trial fo... (7/4/2025) Brii Biosciences Taps Joincare Pharma to... (7/4/2025) Shaanxi Micot Secures 100M CNY in Series... (7/4/2025) Vaccine Sales Collapse in China as MNCs ... (7/3/2025) AbbVie's Venclexta Approved in China for... (7/3/2025) Eli Lilly's Tirzepatide Approved in Chin... (7/3/2025) Hengrui Medicine Gains NMPA Approval for... (7/3/2025) CTTQ's Homegrown rFVIIa Wins NMPA Approv... (7/3/2025) Belief BioMed Unveils 4-Year Follow-Up D... (7/3/2025) Cloudbreak Pharma Debuts on HKEX, Raisin... (7/3/2025) Akeso Launches Clinical Trials for First... (7/3/2025) Dizal's Lung Cancer Pill Gains FDA Nod, ... (7/3/2025) CStone Expands Pipeline with Novel BsAb ... (7/3/2025) API China 2025 Ends with High Attendance... (7/2/2025) China to Eliminate CD Submission Require... (7/2/2025)

China's Pharma Market Faces Mixed Performance in Q1 202... China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ... NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co...

Shaanxi Micot Secures 100M CNY in Series D Financing Brii Biosciences Taps Joincare Pharma to Drive BRII‑69... AstraZeneca Eyes $15B Deal for Summit's Chinese-Develop... CStone Expands Pipeline with Novel BsAb Targeting Autoi... Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Millio...

CDE Seeks Comment on Revised eCTD Technical Documents a... CDE Solicits Comments on the 95th Batch of Reference Fo... China Issues Technical Guidance for Clinical Resistance... China to Eliminate CD Submission Requirement for Clinic... CDE Seeks Feedback on Draft Guidelines for Pharma Chang...

NHSA Seeks Public Input on 2025 Drug Reimbursement and ... China Raises Per Capita Public Health Funding to Suppor... China Issues Guidelines to Promote TCM and Western Medi... China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem...

Record China Pharma Monopoly Fine Sends Strong Deterren... Conjupro Files USPTO Challenge on Ascletis' U.S. Patent... China's Draft National Medical Security Law: Seven Key ... China Releases Draft Medical Security Law for Public Co... Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche...

API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ...

Legend Initiates First-in-Human Trial for LUCAR-G19 in ... Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Riv... Akeso Launches Clinical Trials for First Bispecific ADC Belief BioMed Unveils 4-Year Follow-Up Data for Hemophi... CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...